Intake of trans fat and all-cause mortality in the reasons for geographical and racial differences in stroke (REGARDS) cohort1-4

American Journal of Clinical Nutrition

Volumn 97, Issue 5, 2013, Pages 1121-1128

  Kiage, James N ^a   Merrill, Peter D ^b   Robinson, Cody J ^b   Cao, Yue ^d   Malik, Talha A ^d,f   Hundley, Barrett C ^b   Lao, Ping ^c   Judd, Suzanne E ^b   Cushman, Mary ^e   Howard, Virginia J ^b   Kabagambe, Edmond K ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANS FATTY ACID;

ADULT; ARTICLE; ATTRIBUTABLE RISK; CORRELATIONAL STUDY; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; UNITED STATES;

AFRICAN AMERICANS; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SOUTHEASTERN UNITED STATES; STROKE; TRANS FATTY ACIDS;

EID: 84876915581     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.049064     Document Type: Article

References (50)

1. Smit LA, Katan MB, Wanders AJ, Basu S, Brouwer IA. A high intake of trans fatty acids has little effect on markers of inflammation and oxidative stress in humans. J Nutr 2011;141:1673-8.
2. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ,Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med 2006;354:1601-13.
3. Kromhout D, Menotti A, Bloemberg B, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Giampaoli S, Jansen A, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995;24:308-15.
4. Willett WC, Ascherio A. Trans fatty acids: are the effects only marginaľ Am J Public Health 1994;84:722-4.
5. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005;135:562-6.
6. Salmerón J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001;73:1019-26.
7. Chajés V, Thiébaut ACM, Rotival M, Gauthier E, Maillard V, Boutron- Ruault M-C, Joulin V, Lenoir GM, Clavel-Chapelon F. Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC study. Am J Epidemiol 2008;167:1312-20
8. Hu J, La Vecchia C, Gibbons L, Negri E, Mery L. Nutrients and risk of prostate cancer. Nutr Cancer 2010;62:710-8.
9. Yaemsiri S, Sen S, Tinker L, Rosamond W, Wassertheil-Smoller S, He K. Trans fat, aspirin, and ischemic stroke in postmenopausal women. Ann Neurol 2012;72:704-15.
10. Astorg P. Dietary fatty acids and colorectal and prostate cancers: epidemiological studies. Bull Cancer 2005;92:670-84.
11. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009;6:e1000058.
12. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology 2005;25(3):135-43.
13. Kabagambe EK, Judd SE, Howard VJ, Zakai NA, Jenny NS, Hsieh M, Warnock DG, Cushman M. Inflammation biomarkers and risk of allcause mortality in the Reasons for Geographic and Racial Differences in Stroke cohort. Am J Epidemiol 2011;174:284-92.
14. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001;154:1089-99.
15. Mares-Perlman JA, Klein BE, Klein R, Ritter LL, Fisher MR, Freudenheim JL. A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr 1993;123:489-501.
16. Block G, Woods M, Potosky A, Clifford C. Validation of a selfadministered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990;43:1327-35.
17. Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G. Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr 2006;9(1): 84-93.
18. Cushman M, McClure LA, Howard VJ, Jenny NS, Lakoski SG, Howard G. Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem 2009;55:1627-36.
19. Pullicino PM, McClure LA, Wadley VG, Ahmed A, Howard VJ, Howard G, Safford MM. Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke 2009;40:3706-10.
20. Kennedy RE, Howard G, Go RC, Rothwell PM, Tiwari HK, Feng R, McClure LA, Prineas RJ, Banerjee A, Arnett DK. Association between family risk of stroke and myocardial infarction with prevalent risk factors and coexisting diseases. Stroke 2012;43:974-9.
21. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(suppl):1220S-31S.
22. Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB, Levy WC. trans Fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 2004;80:1521-5.
23. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004;79:606-12.
24. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004;79: 969-73.
25. de Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 2001;21:1233-7.
26. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:1146-55.
27. Kabagambe EK, Ordovas JM, Hopkins PN, Tsai MY, Arnett DK. The relation between erythrocyte trans fat and triglyceride, VLDL- and HDL-cholesterol concentrations depends on polyunsaturated fat. PLoS ONE 2012;7:e47430.
28. Hertzmark E, Wand H, Spiegelman D. The SAS PAR macro. Available from: http://www.hsph.harvard.edu/faculty/donna-spiegelman/files/par- documentation-march-2012.pdf (cited 20 June 2012).
29. Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control 2007;18:571-9.
30. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
31. Ye J, Kiage JN, Arnett DK, Bartolucci AA, Kabagambe EK. Shortterm effect of fenofibrate on C-reactive protein: a meta-analysis of randomized controlled trials. Diabetol Metab Syndr 2011;3:24.
32. Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP. Inflammation biomarkers and near-term death in older men. Am J Epidemiol 2007;165:684-95.
33. Amemiya N, Ogawa T, Otsuka K, Ando Y, Nitta K. Comparison of serum albumin, serum C-reactive protein, and pulse wave velocity as predictors of the 4-year mortality of chronic hemodialysis patients. J Atheroscler Thromb 2011;18:1071-9.
34. Xie Q, Zhou Y, Xu Z, Yang Y, Kuang D, You H, Ma S, Hao C, Gu Y, Lin S, et al. The ratio of CRP to prealbumin levels predict mortality in patients with hospital-acquired acute kidney injury. BMC Nephrol 2011;12:30.
35. de Roos NM, Schouten EG, Scheek LM, van Tol A, Katan MB. Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women. Metabolism 2002;51:1534-7.
36. Abbey M, Nestel PJ. Plasma cholesteryl ester transfer protein activity is increased when trans-elaidic acid is substituted for cis-oleic acid in the diet. Atherosclerosis 1994;106(1):99-107.
37. Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C, Lamarche B. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr 2003;78:370-5.
38. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860-7.
39. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002;16(2):217-26, 29; discussion 30-2.
40. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000;54:615-40.
41. Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 2000;51:511-23.
42. García-Rodríguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001;12:88-93.
43. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
44. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517-84.
45. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-26.
46. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC. Trans fatty acids and coronary heart disease. N Engl J Med 1999;340:1994-8.
47. Ratnayake WM, L'Abbe MR, Farnworth S, Dumais L, Gagnon C, Lampi B, Casey V, Mohottalage D, Rondeau I, Underhill L, et al. Trans fatty acids: current contents in Canadian foods and estimated intake levels for the Canadian population. J AOAC Int 2009;92:1258-76.
48. FDA. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule. Fed Regist 2003;68: 41433-506.
49. Brouwer IA, Wanders AJ, Katan MB. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans - a quantitative review. PLoS ONE 2010;5:e9434.
50. Kris-Etherton PM, Lefevre M, Mensink RP, Petersen B, Fleming J, Flickinger BD. Trans fatty acid intakes and food sources in the U.S. population: NHANES 1999-2002. Lipids 2012;47:931-40.